Advertisement

Topics

Latest "autologous Epstein Barr virus transformed lymphoblastoid cell vaccine" News Stories

03:09 EDT 18th August 2017 | BioPortfolio

Here are the most relevant search results for "autologous Epstein Barr virus transformed lymphoblastoid cell vaccine" found in our extensive news archives from over 250 global news sources.

More Information about autologous Epstein Barr virus transformed lymphoblastoid cell vaccine on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about autologous Epstein Barr virus transformed lymphoblastoid cell vaccine for you to read. Along with our medical data and news we also list autologous Epstein Barr virus transformed lymphoblastoid cell vaccine Clinical Trials, which are updated daily. BioPortfolio also has a large database of autologous Epstein Barr virus transformed lymphoblastoid cell vaccine Companies for you to search.

Showing "autologous Epstein Barr virus transformed lymphoblastoid cell vaccine" News Articles 1–25 of 12,000+

Extremely Relevant

T Cells Targeting Epstein-Barr Virus -- A New Treatment for MS?

This new approach -- based on the theory that the Epstein-Barr virus plays a causative role in MS -- has shown encouraging results in a preliminary study. Medscape Medical News


Epstein-Barr virus steers B-cells to hide in plain sight

Viruses are notorious for taking over their host's operations and using them to their own advantage. But few human viruses make themselves quite as cozy as the Epstein-Barr virus, which can be found in an estimated nine out of ten humans without causing...

Researchers show how Epstein-Barr virus manages to persist inside immune system's B cells

Viruses are notorious for taking over their host's operations and using them to their own advantage. But few human viruses make themselves quite as cozy as the Epstein-Barr virus, which can be found in an estimated nine out of ten humans without causing any ill effects.


Researchers Apply New Immune Technologies in Search of Mono Vaccine

Researchers are analyzing the genetics of human immune responses to develop the basis of an effective vaccine or drug therapy against Epstein-Barr Virus, or EBV

Cancer-causing virus masters cell's replication, immortality

(Duke University) Duke researchers detail how the Epstein-Barr virus manages to persist quietly inside the immune system's B cells in as many as 90 percent of adults. Should something go awry however, the virus can cause mononucleosis or cancers of the lymph. 'The challenge is that it's a really efficient pathogen,' said Micah Luftig, an associate professor of molecular genetics and microbiology.

Our Gorilla Cousins Harbor Mono-Like Virus, Too

FRIDAY, July 14, 2017 -- Researchers say a herpes virus similar to the Epstein-Barr virus that infects people has been found in mountain gorillas. The discovery may assist in the conservation of critically endangered mountain gorillas, according to...

Herpes virus in mountain gorillas has similarity to EBV found in humans

Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific Reports.

Mountain gorillas have herpes virus similar to that found in humans

Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific Reports.

Series C round brings £60mm to Cell Medica

Cell Medica Ltd. (cellular immunotherapy) raised £60mm ($73.2mm) through its Series C round from returning investors Touchst...

Early Detection of Nasopharyngeal Cancer With EBV DNA

Screening for Epstein-Barr virus DNA in plasma samples identified nasopharyngeal carcinoma significantly earlier compared with historical controls. Medscape Medical News

Epstein Barr virus, abdominal pain, and jaundice

A 22 year old man presented to the emergency department with abdominal pain, jaundice, itching, and fever. His urine was dark and stools pale.His temperature was 38.7°C and he was icteric with...

Analysis of EBV DNA in plasma samples IDs nasopharyngeal CA

(HealthDay)—Analysis of Epstein-Barr virus (EBV) DNA in plasma samples can identify early asymptomatic nasopharyngeal carcinoma, according to a study published in the Aug. 10 issue of the New England Journal of Medicine.

New vaccine production could improve flu shot accuracy

(Duke University) For decades, vaccine manufacturers have used chicken eggs to grow the flu virus strains included in the seasonal vaccine. But because these human strains frequently mutate to adapt to their new environment, the resulting vaccine is often an imperfect match to the virus that it is supposed to protect against. Duke researchers have devised a way to keep the human influenza virus fr...

Blood Test Can Screen for Rare Sinus Cancer, Study Finds

WEDNESDAY, Aug. 9, 2017 -- A new DNA blood test can catch a rare but deadly form of cancer that occurs in the sinuses, researchers report. The test, which looks for DNA evidence of Epstein-Barr virus in blood samples, was 97 percent accurate at...

One step closer to a DNA vaccine against dengue virus

(Frontiers) In a new study, researchers inoculated mice with a new DNA vaccine candidate (pVAX1-D1ME) in order to evaluate its efficiency. They found that the vaccine candidate was able to induce persistent humoral and cellular immune responses and provided efficient protection against lethal challenge from one of the four serotypes of dengue virus (DV1). These results are encouraging for the futu...

Cell-Based Flu Vaccine Hits Commercial Scale

Rather than rely on poultry and the eggs they produce for the manufacture of yearly flu vaccines, the World Health Organization (WHO) and FDA have encouraged vaccine manufacturers to look to other manufacturing technologies, such as use of a cell-based production model. Seqirus announced on June 21, 2017 that it has successfully used such a model for the large-scale production of the flu vaccine u...

[Personal View] Achieving safe, effective, and durable Zika virus vaccines: lessons from dengue

Newly proposed candidate Zika virus vaccines might or might not succeed in raising safe, effective, and durable protection against human Zika virus infections or syndromes. Analyses of a clinically tested and licensed dengue vaccine that failed to protect seronegative individuals from breakthrough or enhanced dengue infections suggest that poor T-cell immunity might have contributed to protection ...

Kite Pharma seeks European approval for Axicabtagene Ciloleucel

Kite Pharma has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for axicabtagene ciloleucel as a treatment for patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), transformed follicular lymphoma (TFL), and primary mediastinal B-cell lymphoma (PMBCL) who are not eligible for autologous stem cell transplant.

Experimental Zika virus vaccines restrict in utero virus transmission in mice

(NIH/National Institute of Allergy and Infectious Diseases) Two experimental vaccines can restrict Zika virus transmission from pregnant mice to their fetuses and can prevent Zika virus-induced placental damage and fetal demise, according to new findings published in Cell. Scientists from NIAID; Washington University School of Medicine in St. Louis; University of Texas Medical Branch (UTMB); and o...

Make the Diagnosis: Extremity Dilemma

(MedPage Today) -- Case Findings: The mother of a 3-year-old brought her daughter to the pediatrician when she developed a rash of smooth papules across her buttocks that spread outward to her arms and down her legs. It barely appeared on her trunk. She complained that it was itchy and had a fever and enlarged lymph nodes. Just a short time before the rash appeared, the mother reported that her da...

Potential Zika virus vaccine

Preclinical research results in animal models demonstrate favorable outcomes in developing a vaccine against the mosquito-borne Zika virus.

Human Flu Vaccine Triggers Broad Immune Responses against Multiple Strains

An influenza vaccine trial in human volunteers has generated results that could help scientists develop a universal influenza vaccine that offers broad protection against yearly shifting viral strains. In the small-scale Phase I study, a group 2 subtype H7N9 vaccine generated high levels of memory B cells that recognized the conserved stem region of both group 1 and group 2 influenza virus hemaggl...

More-is-better approach appears to improve vaccine protection from HIV-like virus in monkeys

Building on insights from an HIV vaccine regimen in humans that had partial success during a phase 3 clinical trial in Thailand, a Duke-led research team used a more-is-better approach in monkeys that appeared to improve vaccine protection from an HIV-like virus.

Investigational Vaccine Protected Monkeys from HIV-Like Virus

The vaccine adds three more targets to a human vaccine candidate that showed promise

New Polio Virus Evolution Insights Could Lead to Improved Vaccine

NewsThe polio virus used the same three evolutionary steps to evolve from harmless vaccine into a regional menace.


Quick Search
Advertisement
 

News Quicklinks